文献速递瓣膜外科主动脉外科

二叶式主动脉瓣置换术后升主动脉直径进展:外科与经导管对比

Progression of the ascending aorta diameter after surgical or transcatheter bicuspid aortic valve replacement.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

研究前瞻性收集189例因重度二叶式主动脉瓣狭窄行瓣膜置换的患者,比较外科主动脉瓣置换(SAVR)与经导管主动脉瓣植入(TAVI)后升主动脉直径的晚期进展。随访4.6年,SAVR组升主动脉直径进展显著低于TAVI组,TAVI组生存率及无事件生存率显著更低。多变量线性回归显示经导管手术、基线主动脉直径和瓣周漏与术后升主动脉扩张增加显著相关。

要点

  • 随访4.6年,SAVR组升主动脉直径进展0.95 mm,低于TAVI组1.65 mm(P=0.02)。
  • TAVI组生存率(P=0.00013)和无事件生存率(P<0.0001)显著低于SAVR组。
  • 经导管手术、基线主动脉直径和瓣周漏与术后升主动脉扩张增加显著相关。

核心结论

  • 因重度二叶式主动脉瓣狭窄行SAVR的患者,其长期升主动脉直径进展显著低于行经导管手术的患者。

研究设计与样本

  • 前瞻性收集2015年1月至2021年12月连续189例因重度二叶式主动脉瓣狭窄行瓣膜置换的患者,其中SAVR组143例(76%),TAVI组46例(24%)。
  • 手术指征由机构心脏团队审定,主动脉直径通过经胸超声心动图评估,比较两组术前与长期随访的升主动脉直径差异。

主要发现

  • 随访4.6年(标准差1.7年),TAVI组生存率显著低于SAVR组(P=0.00013),无事件生存率亦显著更低(P<0.0001)。
  • 升主动脉直径进展SAVR组为0.95(0.60,1.30)mm,TAVI组为1.65(0.67,2.63)mm,P=0.02。
  • 按体表面积标化的升主动脉直径进展SAVR组为0.72(0.38,1.05)mm/m²,TAVI组为1.05(0.39,1.71)mm/m²,P=0.02。
  • 按身高标化的升主动脉直径进展SAVR组为0.59(0.36,0.81)mm/m,TAVI组为1.11(0.44,1.78)mm/m,P=0.001。
  • 多变量线性回归分析显示,经导管手术、基线主动脉直径和瓣周漏与术后升主动脉扩张增加显著相关。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Ascending aorta (AA) dilatation in patients with bicuspid aortic valve (AV) is related both to genetic and haemodynamic factors. The aim of this study is to compare late progression of AA dilatation in bicuspid AV patients undergoing surgical aortic valve replacement (SAVR) versus transcatheter aortic valve implantation (TAVI). METHODS: Data of 189 consecutive patients who underwent AV replacement for severe bicuspid AV stenosis were prospectively collected. Patients who underwent SAVR were compared to patients who underwent TAVI. Indication to the procedure was validated by the institutional Heart Team. Aortic diameters were evaluated by transthoracic echocardiogram. Differences between preoperative and long-term follow-up AA diameters were compared in the 2 groups. RESULTS: Between January 2015 and December 2021, 143 (76%) patients underwent SAVR and 46 (24%) patients underwent TAVI. At 4.6 (standard deviation 1.7) years follow-up, patients in the TAVI group showed significantly lower survival (P = 0.00013) and event-free survival (P < 0.0001). AA diameter progression was lower in surgical compared to transcatheter patients, 0.95 (0.60, 1.30) vs 1.65 (0.67, 2.63) mm, P = 0.02. AA diameter progression indexed for body surface area and height was lower in the surgical group: 0.72 (0.38, 1.05) vs 1.05 (0.39, 1.71) mm/m2, P = 0.02, and 0.59 (0.36, 0.81) vs 1.11 (0.44, 1.78) mm/m, P = 0.001, respectively. At multivariable linear regression analysis transcatheter procedure, baseline aortic diameter and paravalvular leak were significantly associated with increased postoperative AA dilatation. CONCLUSIONS: Bicuspid AV patients who underwent SAVR, showed significantly less long-term AA diameter progression than patients who underwent transcatheter procedure.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Chiariello GA, Di Mauro M, Pasquini A, et al. Progression of the ascending aorta diameter after surgical or transcatheter bicuspid aortic valve replacement. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38775458. doi:10.1093/icvts/ivae100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。